Corrigendum: Establishment of Tumor Treating Fields Combined With Mild Hyperthermia as Novel Supporting Therapy for Pancreatic Cancer.

Front Oncol

Molecular OncoSurgery, Section Surgical Research, Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Published: March 2022

[This corrects the article DOI: 10.3389/fonc.2021.738801.].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009414PMC
http://dx.doi.org/10.3389/fonc.2022.889215DOI Listing

Publication Analysis

Top Keywords

corrigendum establishment
4
establishment tumor
4
tumor treating
4
treating fields
4
fields combined
4
combined mild
4
mild hyperthermia
4
hyperthermia novel
4
novel supporting
4
supporting therapy
4

Similar Publications

Corrigendum to "Colorectal cancer cells establish metabolic reprogramming with cancer-associated fibroblasts (CAFs) through lactate shuttle to enhance invasion, migration, and angiogenesis" [Int. Immunopharmacol. 143 (2024) 113470].

Int Immunopharmacol

December 2024

Department of Pharmacology, School of Pharmaceutical Sciences, Shandong University, 44 West Wenhua Road, Jinan 250012, China; Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Science, Shandong University, China; Shandong Cancer Hospital and Institute, 440 Jiyan Road, Jinan 250117, Shandong Province, China. Electronic address:

View Article and Find Full Text PDF

Corrigendum: A bibliometric analysis of interstitial cells of Cajal research.

Front Med (Lausanne)

December 2024

Science & Technology Innovation Center (National Key Laboratory Cultivation Base of Chinese Medicinal Powder & Innovative Medicinal Jointly Established by Province and Ministry), Hunan University of Chinese Medicine, Changsha, China.

[This corrects the article DOI: 10.3389/fmed.2024.

View Article and Find Full Text PDF
Article Synopsis
  • The text refers to a correction for a previously published article indicated by the DOI: 10.3389/fpubh.2024.1455718.
  • This correction may address errors or updates that needed to be made to the original study or findings.
  • It highlights the importance of maintaining accuracy and reliability in published research for readers and the academic community.*
View Article and Find Full Text PDF

Corrigendum to "Establishment of human intestinal organoids derived from commercially available cryopreserved intestinal epithelium and evaluation for pharmacokinetic study" [Drug Metabol Pharmacokinet 53 (2024) 100532].

Drug Metab Pharmacokinet

December 2024

Laboratory of Biochemistry and Molecular Biology, School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan; Laboratory of Functional Organoid for Drug Discovery, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Osaka, 567-0085, Japan; Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, 565-0871, Japan; Global Center for Medical Engineering and Informatics, Osaka University, Suita, Osaka, 565-0871, Japan; Center for Infectious Disease Education and Research (CiDER), Osaka University, Suita, Osaka, 565-0871, Japan. Electronic address:

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!